Blanket Purchase Agreement V797D40222-VA24917A0027

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Abbott Molecular Inc. two Blanket Purchase Agreement calls to provide HIV-1 genotyping testing services and associated reagents. Under the first BPA call awarded February 27, 2021 with a completion date of February 26, 2022, Abbott Molecular will deliver ViroSeq reagents for HIV-1 genotyping testing to support clinical care and research programs in Des Plaines, Illinois. This call...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 (VA - VHA VISN 17) awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide GENMARK reagents for diagnostic testing needs. The single award contract has a potential value of $400,000 and a period of performance through July 16, 2028. A firm fixed price delivery order for $63,504 was also issued for one year starting July 17, 2023 for GENMARK reagents to be...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded Abbott Molecular Inc. two blanket purchase agreement call contracts to provide reagents and consumables from the Invitro Diagnostics, Reagents, Test General Services Administration Federal Supply Schedule 65-VII. The first BPA, awarded April 1, 2022 for $2,173,789.61, and the second awarded April 1, 2023 for $1,916,938.17, both have a period of performance through March 31, 2024....

Abbott Molecular Inc., a subsidiary of Abbott Laboratories, has been awarded multiple Federal Supply Schedule (FSS) contracts and Blanket Purchase Agreements (BPAs) by the Department of Veterans Affairs (VA) Veterans Health Administration to provide in vitro diagnostic products, reagents, and services. The contracts, valued up to $11.4 million, utilize the Invitro Diagnostics, Reagents, Test (FSS-65-VII) GSA Schedule and typically involve firm fixed price delivery orders for items such as...

The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) contract to Abbott Molecular Inc., a subsidiary of the global healthcare company Abbott Laboratories. The $12.5 million, 5-year BPA provides the VA with Alinity-M reagent kits, consumables, and related molecular diagnostics equipment and services. The contract does not utilize any set-aside designations, reflecting Abbott Molecular's status as a large, established medical technology provider. Under this BPA,...

The Department of Veterans Affairs (VA), through its Veterans Integrated Service Network (VISN) 16, has awarded a Blanket Purchase Agreement (BPA) to Abbott Laboratories Inc. for the provision of automated hepatitis and HIV testing instrumentation. The BPA, valued up to $5,289,009.35, is issued against Abbott's existing General Services Administration (GSA) Federal Supply Schedule contract for Critical Analyzers and Laboratory equipment. This contract vehicle allows the VA to efficiently procure...

The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 awarded a $10.8 million Blanket Purchase Agreement (BPA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the provision of ALINITY M COVID-19 testing, HIV testing, and HPV testing supplies. The contract has a period of performance through September 21, 2026 and was not set aside for any specific business type. Under this BPA, the VA has awarded multiple firm fixed-price task orders to Abbott Molecular...

The federal agency, the Department of Veterans Affairs Veterans Health Administration (VA), awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The IDC has a ceiling value of $667,159.30 and an ultimate completion date of August 31, 2030, for the provision of REAGENTS AND CONSUMABLES. Under this IDC, a $135,281.86...

The Federal Supply Schedule contract awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, provides a range of molecular diagnostic products and services to the U.S. Department of Veterans Affairs (VA). Under this multiple-award contract, Abbott Molecular will supply equipment, reagents, and testing capabilities related to sexually transmitted infections (STIs) and SARS-CoV-2 on the Alinity M platform. The $2,683,875.95 firm-fixed-price delivery order, awarded by the VA's...

This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide Alinity reagents, controls, and consumables. The BPA has a ceiling value of $3,814,912.30 and a performance period through April 30, 2029. As a leading provider of molecular diagnostic products and services to federal government customers, Abbott Molecular has supplied a range of equipment, reagents, and testing capabilities to...